Best for: Muscle injuries, multiple concurrent injuries, systemic inflammation Distribution: Whole-body via bloodstream Dosing frequency: Twice weekly during loading, once weekly maintenance Half-life: 24 to 48 hours Unique benefit: Reaches all injury sites from single injection Human Clinical Evidence Human clinical trials for Tb-500 remain remarkably sparse given its widespread underground use, but more data exists than for Bpc-157
Clavien, P.-A., Harvey, R
Choosing the Right Approach If youre weighing sermorelin vs ipamorelin , the safest path is to treat this like any other endocrine decision: confirm whether theres a medical indication to influence the GH axis, clarify whether the product is FDA-approved, compounded, or non-approved, define measurable goals and monitoring before starting, and avoid anyone promising guaranteed fat loss or dramatic anti-aging results
Overview Ipamorelin is the first synthetic GHS that appears highly selective